Medical Device News Magazine

Repetitive Game Testing: 3 Ways AI Liberates Developers | By: David Melhart, Ph.D., AI Researcher at modl.ai

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

In a recent article in the Harvard Business Review, authors H. James Wilson and Paul R. Daugherty discussed collaborative intelligence for developing employees. They stated, “Humans and machines can enhance each other’s strengths.” In summary, their research concluded the following:

“Artificial intelligence is transforming all sectors of the economy, but there’s no reason to fear that robots will replace all human employees. In fact, companies that automate their operations mainly to cut their workforces will see only short-term productivity gains, say the authors. Their research, involving 1,500 firms in a range of industries, shows that the biggest performance improvements come when humans and smart machines work together, enhancing each other’s strengths.”

As in many industries, the application of AI in game development intends to enhance humans’ strengths by liberating them from repetitive tasks that could be limiting their creativity or ability to apply their knowledge and expertise in other more productive areas. AI enables game developers to cut the time spent in repetitive game testing, for example.

Game testing requires hours and hours of repetitive, very detailed, and thorough testing for the smallest bugs that could break a game. Let’s discuss three ways in which AI can collaborate with game developers in repetitive testing:

  • Continuous testing: AI can provide ongoing testing for games in production, reducing the time it takes to iterate on new features. This can be especially valuable for games following a live-service model, where new features are being developed continuously during the game’s lifetime. Nevertheless, AI testing can reduce the amount of repetitive human testing in any project, freeing up valuable QA and developer time.
  • Exploratory testing: An AI bot can go anywhere a player could possibly think of going to test and provide information on where the issues in the game reside. By being able to sweep through a large amount of content, AI bots can reliably discover crashes, errors, exceptions, and relative performance changes. This can boost the QA workflow by fast-forwarding the discovery of issues, allowing QA testers to focus on investigation.
  • Actionable reporting: An AI-powered system can deliver actionable reports with game logs, video recordings, and AI insights to help analyze, correct, and test potential issues. By providing a breadth of contextual information and actionable insights, these systems can significantly enhance the game development cycle.

In game development, there is nothing like the experience a developer brings to the table. Adding AI to the mix allows developers’ strengths (creativity, critical thinking, leadership, among others) to stand out while the AI collaborates with data. In simple words, it is about letting the AI bot know what you need, running it, reviewing it, fixing it, and repeating it (if necessary).

AI still has a long way to go in game development, but in the meantime, human/AI collaboration is a step forward to continue to create and develop games that people want to play with the quality that the times require.

About the author:

David Melhart is an AI Researcher at modl.ai, focusing on player modeling and affective computing. Melhart earned his Ph.D. at the University of Malta, Institute of Digital Games. While working as an AI Researcher for modl.ai since 2019, David also remains connected to academia. As a Post-Doc and Research-Support Officer at the University of Malta, Institute of Digital Games, David is involved in teaching the next generation of game AI researchers artificial intelligence and affective computing.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”